Mobia Medical, Inc.
- MOBI ยท Nasdaq
- Surgical & Medical Instruments & Apparatus
- Austin, TX
- CIK 0001489993
Updated from SEC filings through
Top things to know
Executives
- Richard J. Foust President & CEO 4, 2026-05-11
- Nelson Bunker Curnes Chief Financial Officer 4, 2026-06-11
- Prashant B. Rawat Chief Operating Officer 4, 2026-09-04
- Douglas T. Ellison Chief Commercial Officer 4, 2026-05-11
What leadership is saying
“This quarter, we delivered our strongest results yet. Revenue growth of 73% reflects the strength of our commercial execution and the predictable nature of our patient funnel”
Earnings press release (8-K Ex. 99.1), filed November 5, 2026
Mobia Medical, Inc. is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Austin, TX. It trades as MOBI on Nasdaq. Richard J. Foust is President & CEO.
Five-year financials
We have no annual financials for this company yet.
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Richard J. Foust | President & CEO | 4, 2026-05-11 |
| Nelson Bunker Curnes | Chief Financial Officer | 4, 2026-06-11 |
| Prashant B. Rawat Medical Device Development Executive | Chief Operating Officer | 4, 2026-09-04 |
| Douglas T. Ellison | Chief Commercial Officer | 4, 2026-05-11 |
What Mobia Medical, Inc. does
We are a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Our Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the first and only clinically-validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Stroke is one of the leading causes of long-term disability in the United States.
Shares and governance
| Shares outstanding | 33.3 million (as of October 30, 2026) | 10-Q, November 5, 2026 |
|---|---|---|
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| September 11, 2026 | Chase C. Leavitt SEE REMARKS | Buy | 2,000 | $21K | Form 4, September 15, 2026 |
| August 18, 2026 | Casey M. Tansey Director | Buy | 16,441 | $198K | Form 4, August 20, 2026 |
| August 17, 2026 | Casey M. Tansey Director | Buy | 68,559 | $797K | Form 4, August 17, 2026 |
| June 9, 2026 | Nelson Bunker Curnes Chief Financial Officer | Buy | 5,000 | $64K | Form 4, June 11, 2026 |
| May 11, 2026 | Casey M. Tansey Director | Buy | 66,666 | $1000K | Form 4, May 11, 2026 |
| May 11, 2026 | William T. Harrington Director | Buy | 533,333 | $8.0M | Form 4, May 11, 2026 |
| May 11, 2026 | Cynthia L. Lucchese Director | Buy | 125,000 | $1.9M | Form 4, May 11, 2026 |
| May 11, 2026 | Chase C. Leavitt See Remarks | Buy | 3,000 | $45K | Form 4, May 11, 2026 |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-11
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-03
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-07-15
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-05-11
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
Frequently asked questions about Mobia Medical, Inc.
- What does Mobia Medical, Inc. do?
- In its own words, from Item 1 of its 10-K: "We are a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Our Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the first and only clinically-validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Stroke is one of the leading causes of long-term disability in the United States."
- Who is the CEO of Mobia Medical, Inc.?
- Richard J. Foust, President & CEO, as named in a 4 filed May 11, 2026.
- Who is the CFO of Mobia Medical, Inc.?
- Nelson Bunker Curnes, Chief Financial Officer, as named in a 4 filed June 11, 2026.
- Where is Mobia Medical, Inc. headquartered?
- Austin, TX.
- What is Mobia Medical, Inc.'s stock ticker?
- MOBI on Nasdaq.
- What industry is Mobia Medical, Inc. in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is Mobia Medical, Inc.'s website?
- mobia.com. Investor relations: https://ir.mobia.com/.
- When does Mobia Medical, Inc. report earnings next?
- November 10, 2026. Source: pg_earnings_events.
- Is Mobia Medical, Inc. a public company?
- Yes. Mobia Medical, Inc. files with the SEC under CIK 0001489993 and trades as MOBI.
- How many shares of Mobia Medical, Inc. are outstanding?
- 33.3 million shares as of October 30, 2026, from its 10-Q filed November 5, 2026.
- How many business segments does Mobia Medical, Inc. report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- Have Mobia Medical, Inc. insiders traded stock recently?
- Since May 11, 2026, officers and directors reported 0 open-market sales and 9 purchases worth about $12.1M on Forms 4 and 5. The most recent: Chase C. Leavitt (SEE REMARKS) bought 2,000 shares on September 11, 2026.